These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8887292)

  • 1. Amyloid beta 2-microglobulin is modified with N epsilon-(carboxymethyl)lysine in dialysis-related amyloidosis.
    Niwa T; Sato M; Katsuzaki T; Tomoo T; Miyazaki T; Tatemichi N; Takei Y; Kondo T
    Kidney Int; 1996 Oct; 50(4):1303-9. PubMed ID: 8887292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N epsilon-(carboxymethyl)lysine in blood from maintenance hemodialysis patients may contribute to dialysis-related amyloidosis.
    Motomiya Y; Oyama N; Iwamoto H; Uchimura T; Maruyama I
    Kidney Int; 1998 Oct; 54(4):1357-66. PubMed ID: 9767556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid beta 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis.
    Niwa T; Katsuzaki T; Miyazaki S; Momoi T; Akiba T; Miyazaki T; Nokura K; Hayase F; Tatemichi N; Takei Y
    Kidney Int; 1997 Jan; 51(1):187-94. PubMed ID: 8995733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular heterogeneity of amyloid beta2-microglobulin and modification with advanced glycation end products.
    Mironova R; Niwa T
    J Chromatogr B Biomed Sci Appl; 2001 Jul; 758(1):109-15. PubMed ID: 11482729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
    Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
    Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis.
    Miyata T; Taneda S; Kawai R; Ueda Y; Horiuchi S; Hara M; Maeda K; Monnier VM
    Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2353-8. PubMed ID: 8637877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of beta 2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum.
    Niwa T; Katsuzaki T; Momoi T; Miyazaki T; Ogawa H; Saito A; Miyazaki S; Maeda K; Tatemichi N; Takei Y
    Kidney Int; 1996 Mar; 49(3):861-7. PubMed ID: 8648931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremia.
    Degenhardt TP; Grass L; Reddy S; Thorpe SR; Diamandis EP; Baynes JW
    Kidney Int; 1997 Oct; 52(4):1064-7. PubMed ID: 9328946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
    Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
    J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoguanidine inhibits advanced glycation end products formation on beta2-microglobulin.
    Hou FF; Boyce J; Chertow GM; Kay J; Owen WF
    J Am Soc Nephrol; 1998 Feb; 9(2):277-83. PubMed ID: 9527404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis-related amyloidosis: pathogenesis focusing on AGE modification.
    Niwa T
    Semin Dial; 2001; 14(2):123-6. PubMed ID: 11264780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of beta 2-microglobulin with D-glucose or 3-deoxyglucosone inhibits A beta 2M amyloid fibril extension in vitro.
    Hashimoto N; Naiki H; Gejyo F
    Amyloid; 1999 Dec; 6(4):256-64. PubMed ID: 10611946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis.
    Fujimoto N; Yajima M; Ohnishi Y; Tajima S; Ishibashi A; Hata Y; Enomoto U; Konohana I; Wachi H; Seyama Y
    J Invest Dermatol; 2002 Mar; 118(3):479-84. PubMed ID: 11874487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of dialysis-related amyloidosis.
    Miyata T; Maeda K
    Curr Opin Nephrol Hypertens; 1995 Nov; 4(6):493-7. PubMed ID: 8591057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.
    Miyata T; Oda O; Inagi R; Iida Y; Araki N; Yamada N; Horiuchi S; Taniguchi N; Maeda K; Kinoshita T
    J Clin Invest; 1993 Sep; 92(3):1243-52. PubMed ID: 8376584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymerization of normal and intact beta 2-microglobulin as the amyloidogenic protein in dialysis-amyloidosis.
    Campistol JM; Bernard D; Papastoitsis G; Solé M; Kasirsky J; Skinner M
    Kidney Int; 1996 Oct; 50(4):1262-7. PubMed ID: 8887286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody against N(epsilon)-(carboxymethyl)lysine: an advanced glycation end product of the Maillard reaction.
    Shibayama R; Araki N; Nagai R; Horiuchi S
    Diabetes; 1999 Sep; 48(9):1842-9. PubMed ID: 10480617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.
    Reddy S; Bichler J; Wells-Knecht KJ; Thorpe SR; Baynes JW
    Biochemistry; 1995 Aug; 34(34):10872-8. PubMed ID: 7662668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis.
    Iida Y; Miyata T; Inagi R; Sugiyama S; Maeda K
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1235-41. PubMed ID: 8024566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine-specific cleavage of beta 2-microglobulin in amyloid deposits associated with hemodialysis.
    Linke RP; Hampl H; Lobeck H; Ritz E; Bommer J; Waldherr R; Eulitz M
    Kidney Int; 1989 Oct; 36(4):675-81. PubMed ID: 2509779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.